FDA Gives Merck Green Light To Market Keytruda Lung Cancer Drug

Merck's cancer drug Keytruda got the nod of U.S. regulators as a first-line drug for treating metastatic non-small cell lung cancer. For the pharmaceutical company, the FDA approval opens a big market for it.